T helper type 2 locus control region associated RNA (TH2LCRR)

The T helper type 2 locus control region associated RNA (TH2LCRR) is a long non-coding RNA (lncRNA) transcribed from the T helper type 2 (Th2) cytokine gene locus. The Th2 locus control region (LCR) is a complex regulatory element regulating chromatin architecture and transcriptional activity of Th2 cytokine genes (IL-4, IL-5, IL-13) and is essential for their coordinated expression in Th2 immune responses, particularly in allergic inflammation and asthma models[1][2][3][4][5][6][7]. The RNA species itself, TH2LCRR, is annotated as a lncRNA but has no experimentally validated biological function or druggability; the scientific literature implicates the DNA region (the LCR) as essential for cytokine gene expression and immune processes, but specific information about the function, disease involvement, or therapeutic targeting of the RNA transcript (TH2LCRR) is lacking[5]. The TH2LCRR RNA is not considered a therapeutic target such as a receptor, enzyme, or transporter. References to "TH2-LCR" or "Th2 locus control region" in immunology most often concern the *DNA element* (acting as a cis-regulatory module) rather than the RNA transcript, which is currently best regarded as an inferred, uncharacterized lncRNA[5]. Therefore, there is insufficient evidence to treat TH2LCRR as a bona fide drug target, and many references citing TH2-LCR are likely discussing the locus' regulatory DNA sequences rather than the RNA transcript. If a therapeutic target is intended, the correct subject is likely the cis-regulatory locus rather than this RNA species. Summary of issues: - The target as stated (TH2LCRR RNA) is a described lncRNA with no established therapeutic relevance, no clear molecular function, and is not a canonical target class[5]. - Most published literature refers to the locus control region at the *DNA level*[1][2][3][4]. - No drugs, biomarkers, or mechanism of action information specific to the RNA are documented. - Thus, this entry should be flagged as incorrect for drug discovery or target databases, as it is not a druggable or established molecular target. Further comments: If the intended target concerns the *regulatory element* (Th2 locus control region/LCR), it would be more accurately described as a "cis-regulatory element" involved in immune cell function[1][2]. If an lncRNA transcript from this region is later validated as functional, the entry can be updated.

Other names

TH2-LCRTH2 locus control region associated RNATH2LCRR

Not established